Medically integrated dispensing improves oncology treatment coordination through EMR-based care, but payer restrictions remain a key barrier.
Sam Abdelghany, PharmD, MHA
Advertisement
Sam Abdelghany, PharmD, is an executive director of oncology pharmacy at Smilow Cancer Hospital at Yale-New Haven Health.
Articles by Sam Abdelghany, PharmD, MHA
The foundation of medically integrated pharmacy includes 7 critical pillars. This commentary focuses on the benefits of 3 of those pillars: abandonment, adherence, and access/affordability.
Advertisement
Latest Updated Articles
Physician-Pharmacy Integration in Cancer Care: Pillars of Medically Integrated PharmacyPublished: December 16th 2025 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
FDA to Restrict Ingredients Used in Mass-Marketed Compounded GLP-1s, Crack Down on Misleading Ads
2
TrumpRx Launch Brings Savings—and Uncertainty
3
MID Models Reduce Adverse Events, Lower Costs in Oncology: Kenneth Komorny, PharmD, BCPS
4
Contributor: Reimagining Beneficiary Engagement in Accountable Care Models to Make America Healthy Again
5
